Nov 1, 2018 In the Pipeline-Tourette Syndrome: Novel D1 Receptor Antagonist Reduces Tics in Tourette ... In the Pipeline-Tourette Syndrome: Novel D1 Receptor Antagonist Reduces Tics in Tourette …“Tourette syndrome is one of many neurological conditions with a significant unmet need,” lead author Donald Gilbert, MD, MS, FAAN, director of the ... read morePublished on 2018-11-01